Cholecystokinin octapeptide decreases intake of solid food in man. 1982

G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner

Cholecystokinin octapeptide (CCK-OP) was reported to decrease the intake of liquid food in lean and in obese man. This study investigated the effect of CCK-OP on the consumption of real life food, i.e., of standardized sandwiches. Sixteen young non-obese females and males participated, after an overnight fast, each in two experiments. After a basal 30 min, saline or CCK-OP, 1.5 or 3.0 Ivy Dog Units/kg body weight/15 min, was infused in random double blind fashion, while sandwiches were placed in front of the subjects. For the next three 15-min periods, the subjects were instructed to eat as much as they liked. In the first 15 min after 3.0 as well as 1.5 U CCK-OP/kg/15 min significantly fewer sandwiches (50 and 17 percent) were eaten than after saline (p less than 0.01 and p less than 0.05) and less hunger was reported (p less than 0.02 and p less than 0.05). Self-reported activation decreased only with 3.0 U CCK-OP (p less than 0.005). Reports of well-bring , electroencephalogram, heart rate, and respiration were not altered. The results support the notion that CCK is involved in the regulation of food intake.

UI MeSH Term Description Entries
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006815 Hunger The desire for FOOD generated by a sensation arising from the lack of food in the STOMACH.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
February 1981, The American journal of clinical nutrition,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
May 1993, The American journal of physiology,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
October 1982, Physiology & behavior,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
April 1989, The Journal of endocrinology,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
January 1988, Physiology & behavior,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
June 1982, The Proceedings of the Nutrition Society,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
September 1973, Journal of comparative and physiological psychology,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
May 1997, Obesity research,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
October 1989, The American journal of physiology,
G Stacher, and H Steinringer, and G Schmierer, and C Schneider, and S Winklehner
February 1990, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!